Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Letter to BJPsych in response to Horowitz and Moncrieff — Siegfried Kasper (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Letter to BJPsych in response to Horowitz and Moncrieff
Shared by
Eduard Vieta
Letter to BJPsych in response to Horowitz and Moncrieff
Letter
2021
en
Authors
+2 more
SK
Siegfried Kasper
AY
Allan H. Young
Eduard Vieta
Abstract
1 min read
Depression Rating Scale (MADRS)
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2004
Lower activities of serum peptidases predict higher depressive and anxiety levels following interferon‐alpha‐based immunotherapy in patients with hepatitis C
Michael Maes
,
S. Bonaccorso
Article
2002
Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System
Stefania Bonaccorso
,
Valentina Marino
,
Antonella Puzella
,
Massimo Pasquini
,
Massimo Biondi
,
Marco Artini
,
C. Almerighi
,
Robert Verkerk
,
Herbert Y. Meltzer
,
Michael Maes
Article
2010
Treatment Options for Bipolar Depression
Eduard Vieta
,
Julie Locklear
,
Oliver Günther
,
Mattias Ekman
,
Carolin Miltenburger
,
Mary Lou Chatterton
,
Mikael Åström
,
Björn Paulsson
Article
2016
A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
Michael E. Thase
,
Atul R. Mahableshwarkar
,
Marianne Dragheim
,
Henrik Loft
,
Eduard Vieta
Article
2020
156 The Broad Efficacy of Cariprazine Across Symptoms in Patients with Bipolar I Disorder: Post Hoc Analysis of Randomized, Placebo-Controlled Trials
Lakshmi N. Yatham
,
Eduard Vieta
,
Roger S. McIntyre
,
Rakesh K. Jain
,
Willie Earley
,
Mehul Patel
Discussion(0)
No comments yet. Be the first to comment.